International Journal of Family & Community Medicine,
Journal Year:
2025,
Volume and Issue:
9(2), P. 27 - 34
Published: Jan. 1, 2025
Introduction:
It
has
been
documented
that
SARS-CoV-2
infection
can
cause
alterations
in
brain
function,
although
the
specific
neurocognitive
sequelae
are
not
yet
fully
understood.
Mechanisms
involved
include
inflammation
mediated
by
proinflammatory
cytokines
such
as
IL-4
and
IL-6,
generation
of
autoantibodies
an
abnormal
TH2-mediated
immune
response.
In
addition,
other
mechanisms
reactivation
latent
viruses,
direct
viral
invasion
into
central
nervous
system,
disruption
blood-brain
barrier,
hypercoagulation
presence
microhaemorrhages
have
proposed,
all
which
may
contribute
to
pathophysiology
neurological
damage.
General
objective:
To
determine
association
between
cognitive
impairment
mild
post-COVID
19
older
adults
Family
Medicine
Unit
No.
64
“Instituto
Mexicano
del
Seguro
Social”
(Mexican
Institute
Social
Security
(IMSS,
for
its
acronym
Spanish)).
Material
methods:
A
cross-sectional
analytical
study
aged
60-65
years
old
with
confirmed
rapid
antigen
test
was
carried
out.
Sixty-four
subjects
per
group
were
included
selected
non-probabilistic
convenience
sampling.
The
analysed
Pearson’s
chi-squared
test,
multiple
binary
logistic
regression
applied
control
confounding
factors.
Results:
Out
a
total
128
subjects,
93.8%
participants
cognitively
impaired.
Of
these,
59.6%
had
comorbidities,
systemic
arterial
hypertension
being
most
prevalent.
multivariate
analysis,
associated
OR
6.86
[95%
CI
p<0.05].
contrast,
T2D
[OR
1.36
(95%
CI)
p
.53],
SAH
(OR
1.25,
95%
CI,
.651)
obesity
1.14,
.810).
Conclusion:
Cognitive
positivity,
highlighting
importance
assessment
at
primary
care
level
Mexico.
Psychiatry and Clinical Neurosciences,
Journal Year:
2022,
Volume and Issue:
77(2), P. 84 - 93
Published: Nov. 17, 2022
Although
some
patients
have
persistent
symptoms
or
develop
new
following
coronavirus
disease
2019
(COVID-19)
infection,
neuropsychiatric
aspects
of
long
COVID
are
not
well
known.
This
review
summarizes
and
provides
an
update
on
the
dimensions
COVID.
Its
manifestations
commonly
include
fatigue,
cognitive
impairment,
sleep
disorders,
depression,
anxiety,
post-traumatic
stress
disorder.
There
no
specific
tests
for
COVID,
but
characteristic
findings
such
as
hypometabolism
positron
emission
tomography
been
reported.
The
possible
mechanisms
inflammation,
ischemic
effects,
direct
viral
invasion,
social
environmental
changes.
Some
patient
characteristics
severity
complications
acute
COVID-19
infection
may
be
associated
with
increased
risk
symptoms.
Long
resolve
spontaneously
persist,
depending
type
established
treatments
lacking,
various
psychological
pharmacological
attempted.
Vaccination
against
plays
a
key
role
in
prevention
disease.
With
differences
among
SARS-CoV-2
variants,
including
omicron
variant,
likely
to
change
future.
Further
studies
clarifying
effective
warranted.
Journal of Neurology,
Journal Year:
2023,
Volume and Issue:
270(5), P. 2392 - 2408
Published: March 20, 2023
Patients
with
post-coronavirus
disease
2019
(COVID-19)
conditions
typically
experience
cognitive
problems.
Some
studies
have
linked
COVID-19
severity
long-term
damage,
while
others
did
not
observe
such
associations.
This
discrepancy
can
be
attributed
to
methodological
and
sample
variations.
We
aimed
clarify
the
relationship
between
outcomes
determine
whether
initial
symptomatology
predict
Cognitive
evaluations
were
performed
on
109
healthy
controls
319
post-COVID
individuals
categorized
into
three
groups
according
WHO
clinical
progression
scale:
severe-critical
(n
=
77),
moderate-hospitalized
73),
outpatients
169).
Principal
component
analysis
was
used
identify
factors
associated
symptoms
in
acute-phase
domains.
Analyses
of
variance
regression
linear
models
study
intergroup
differences
The
group
significantly
worse
than
control
general
cognition
(Montreal
Assessment),
executive
function
(Digit
symbol,
Trail
Making
Test
B,
phonetic
fluency),
social
(Reading
Mind
Eyes
test).
Five
components
emerged
from
principal
analysis:
"Neurologic/Pain/Dermatologic"
"Digestive/Headache",
"Respiratory/Fever/Fatigue/Psychiatric"
"Smell/
Taste"
predictors
Montreal
Assessment
scores;
predicted
attention
working
memory;
verbal
memory,
"Respiratory/Fever/Fatigue/Psychiatric,"
"Neurologic/Pain/Dermatologic,"
"Digestive/Headache"
function.
severe
exhibited
persistent
deficits
Several
sequelae,
indicating
role
systemic
inflammation
neuroinflammation
COVID-19."
Study
Registration:
www.ClinicalTrials.gov
,
identifier
NCT05307549
NCT05307575.
Brain Behavior & Immunity - Health,
Journal Year:
2023,
Volume and Issue:
27, P. 100587 - 100587
Published: Jan. 5, 2023
Subjective
and
objective
cognitive
dysfunction
are
reported
after
COVID-19
but
with
limited
data
on
their
congruence
associations
the
severity
of
acute
disease.
The
aim
this
cohort
study
is
to
describe
prevalence
subjective
at
three
six
months
symptoms
psychological
disease-related
factors.We
assessed
a
184
patients
COVID-19:
82
admitted
Intensive
Care
Unit
(ICU),
53
regular
hospital
wards,
49
isolated
home.
A
non-COVID
control
group
individuals
was
included.
Demographic
clinical
were
collected.
symptoms,
impairment,
depressive
post-traumatic
stress
disorder
(PTSD)
assessed.At
months,
impairment
by
32.3%
ICU-treated,
37.3%
ward-treated,
33.3%
home-isolated
observed
in
36.1%
34.7%
8.9%
patients.
associated
PTSD
female
sex,
not
assessment
or
metrics.One-third
patients,
regardless
disease
severity,
high
levels
which
results
from
screening
demographic
factors.
Our
stresses
importance
thorough
reporting
long-term
for
underlying
mental
health
related
factors
such
as
depression.
Journal of Alzheimer s Disease Reports,
Journal Year:
2023,
Volume and Issue:
7(1), P. 119 - 128
Published: Feb. 2, 2023
Background:
Cognitive
postscripts
of
COVID-19,
codenamed
as
‘cognitive
COVID’
or
‘brain
fog,’
characterized
by
multidomain
cognitive
impairments,
are
now
being
reckoned
the
most
devastating
sequelae
COVID-19.
However,
impact
on
already
demented
brain
has
not
been
studied.
Objective:
We
aimed
to
assess
functioning
and
neuroimaging
following
SARS-CoV-2
infection
in
patients
with
pre-existing
dementia.
Methods:
Fourteen
COVID-19
survivors
dementia
(four
Alzheimer’s
disease,
five
vascular
dementia,
three
Parkinson’s
disease
two
behavioral
variant
frontotemporal
dementia)
were
recruited.
All
these
had
detailed
evaluations
within
months
before
suffering
from
one
year
later.
Results:
Of
14
patients,
ten
required
hospitalization.
developed
increased
white
matter
hyperintensities
that
mimicked
multiple
sclerosis
small
vessel
disease.
There
was
a
significant
increase
fatigue
(
p
=
0.001)
depression
0.016)
scores
The
mean
Frontal
Assessment
Battery
(p
<
Addenbrooke’s
Examination
also
significantly
worsened.
Conclusion:
rapid
progression
addition
further
impairments/deterioration
abilities,
new
appearance
lesion
burden
suggest
previously
compromised
brains
have
little
defense
withstand
insult
(i.e.,
‘second
hit’
like
infection/dysregulated
immune
response,
inflammation).
‘Brain
fog’
is
an
ambiguous
terminology
without
specific
attribution
spectrum
post-COVID-19
sequelae.
propose
codename,
i.e.
‘FADE-IN
MEMORY’
Fatigue,
decreased
Fluency,
Attention
deficit,
Depression,
Executive
dysfunction,
slowed
INformation
processing
speed,
subcortical
MEMORY
impairment).
JMIR Aging,
Journal Year:
2022,
Volume and Issue:
5(2), P. e36825 - e36825
Published: March 14, 2022
Early
detection
of
dementia
is
critical
for
intervention
and
care
planning
but
remains
difficult.
Computerized
cognitive
testing
provides
an
accessible
promising
solution
to
address
these
current
challenges.
Journal of Personalized Medicine,
Journal Year:
2022,
Volume and Issue:
12(12), P. 2070 - 2070
Published: Dec. 15, 2022
The
present
study
aims
to
provide
a
critical
overview
of
the
literature
on
relationships
between
post-acute
COVID-19
infection
and
cognitive
impairment,
highlighting
limitations
confounding
factors.
A
systematic
search
articles
published
from
1
January
2020
July
2022
was
performed
in
PubMed/Medline.
We
followed
Preferred
Reporting
Items
for
Systematic
Reviews
Meta-Analyses
(PRISMA)
guidelines.
Only
studies
using
validated
instruments
assessment
impairment
were
included.
Out
5515
screened
records,
72
met
inclusion
criteria.
available
evidence
revealed
presence
executive
functions,
speed
processing,
attention
memory
subjects
recovered
COVID-19.
However,
several
reviewed
should
be
highlighted:
most
small
samples,
not
stratified
by
severity
disease
age,
used
as
cross-sectional
or
short-term
longitudinal
design
provided
limited
different
domains.
Few
investigated
neurobiological
correlates
deficits
individuals
Further
with
an
adequate
methodological
are
needed
in-depth
characterization
American Journal of Physical Medicine & Rehabilitation,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 3, 2024
ABSTRACT
Objective
To
determine
the
effects
of
Enhanced
External
Counterpulsation
(EECP)
in
patients
with
long
COVID
and
objectively
assessed
cognitive
impairment.
Design
A
retrospective
evaluation
referred
for
EECP,
sequela,
having
completed
an
objective
digital
assessment
before
after
therapy.
Patients
had
either
impairment
(CI)
or
no
(NCI)
at
baseline.
We
changes
composite
score
using
multi-factor
ANOVA.
Multiple
linear
logistic
regression
analyses
were
conducted
to
evaluate
several
independent
variables.
Results
80
(38
CI
vs
42
NCI)
included
analyses.
All
baseline
characteristics
well
matched.
There
was
significant
improvement
post-EECP
those
notable
documented
safety
concerns.
Conclusion
This
is
first
study
showing
that
EECP
led
functioning
defined
Although
a
lack
negative
control
group
limitation
this
study,
appears
be
highly
safe
effective
potential
widespread
application.
BMC Infectious Diseases,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Jan. 11, 2024
Abstract
Background
This
study
aimed
to
assess
the
construct
validity
and
reliability
of
Iranian
version
COVID-19
Yorkshire
Rehabilitation
Scale
(C19-YRS)
among
elderly
population.
Method
A
cohort
230
individuals
who
tested
positive
for
Covid-19
via
PCR
were
administered
a
health
demographic
information
questionnaire
along
with
C19-YRS.
Both
exploratory
confirmatory
factor
analyses
conducted,
Cronbach’s
alpha
was
calculated.
Results
Findings
from
C19-YRS
revealed
alterations
compared
original
version,
resulting
in
an
adapted
three
factors
achieved
by
redistributing
questions.
These
accounted
57.46%
total
variance.
Despite
relatively
lower
loading
6th
question,
it
retained
due
its
significance
elderly.
The
subscales
ranged
0.730
0.890,
indicating
acceptable
reliability.
Conclusion
validation
results
indicated
well-adjusted
structure
internal
consistency,
affirming
utility
this
tool
Consequently,
Iran
can
serve
as
valuable
resource
healthcare
settings,
aiding
assessment
chronic
complications
arising
It
be
utilized
initial
screening
or
triage
test
evaluate
effectiveness
interventions.